Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor

Molecular Pharmacology

Volumn 72, Issue 6, 2007, Pages 1508-1521

  Singh, Narendra P ^a   Hegde, Venkatesh L ^a   Hofseth, Lorne J ^b   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CASPASE 3; CASPASE 8; CASPASE 9; CHEMOKINE; CYTOCHROME C; CYTOKINE; EOTAXIN; ESTROGEN RECEPTOR; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYPHENOL DERIVATIVE; RANTES; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; ENZYME RELEASE; GRAPE; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PLANT PRODUCT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPINAL CORD; T LYMPHOCYTE; TREATMENT RESPONSE;

ANIMALS; APOPTOSIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; STILBENES; T-LYMPHOCYTE SUBSETS;

EID: 36348975230     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.038984     Document Type: Article

References (45)

1. Atten MJ, Godoy-Romero E, Attar BM, Milson T, Zopel M, and Holian O (2005) Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs 23:111-119.
2. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342.
3. Baur JA and Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
4. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, Kofler R, and Csordas A (2000) Resveratrol causes arrest in the S-phase prior to Fasindependent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ 7:834-842.
5. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, and Pezzuto JM (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61:7456-7463.
6. Bowers JL, Tyulmenkov VV, Jernigan SC, and Klinge CM (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141:3657-3667.
7. Camacho IA, Nagarkatti M, and Nagarkatti PS (2004) Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 78:96-106.
8. Camacho IA, Singh N, Hegde VL, Nagarkatti M, and Nagarkatti PS (2005) Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol 175:90-103.
9. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, and Savouret JF (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56:784-790.
10. Celotti E, Ferrarini R, Zironi R, and Conte LS (1996) Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr A 730:47-52.
11. Cignarella A, Minici C, Bolego C, Pinna C, Sanvito P, Gaion RM, and Puglisi L (2006) Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr Metab Cardiovasc Dis 16:322-329.
12. Clément MV, Hirpara JL, Chawdhury SH, and Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996-1002.
13. de la Lastra CA and Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49:405-430.
14. de Medina P, Casper R, Savouret JF, and Poirot M (2005) Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J Med Chem 48:287-291.
15. Delmas D, Rebe C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N, et al. (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem 278:41482-41490.
16. Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, and Barnes PJ (2004) Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287:L774-L783.
17. Dörrie J, Gerauer H, Wachter Y, and Zunino SJ (2001) Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 61:4731-4739.
18. Fukuyama S, Inoue H, Aizawa H, Oike M, Kitaura M, Yoshie O, and Hara N (2000) Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. Am J Respir Crit Care Med 161:1844-1849.
19. Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, and Gautam SC (2002) Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 132:2076-2081.
20. Gehm BD, McAndrews JM, Chien PY, and Jameson JL (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 94:14138-14143.
21. Humrich J and Riemekasten G (2006) [Regulatory T cells in rheumatic diseases]. Dtsch Med Wochenschr 131:2288-2291.
22. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, and Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702.
23. Iwakura Y and Ishigame H (2006) The IL-23/IL-17 axis in inflammation. J Clin Invest 116:1218-1222.
24. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
25. Jiang S, Lechler RI, He XS, and Huang JF (2006a) CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance. Expert Opin Biol Ther 6:1003-1009.
26. Jiang S, Lechler RI, He XS, and Huang JF (2006b) Regulatory T cells and transplantation tolerance. Hum Immunol 67:765-776.
27. Kim R, Emi M, and Tanabe K (2006a) Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 119:254-264.
28. Kim YA, Lim SY, Rhee SH, Park KY, Kim CH, Choi BT, Lee SJ, Park YM, and Choi YH (2006b) Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 17:1069-1075.
29. Kopp P (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138:619-620.
30. Liu HS, Pan CE, Yang W, and Liu XM (2003) Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol 9:1474-1476.
31. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508.
32. Marier JF, Chen K, Prince P, Scott G, del Castillo JR, and Vachon P (2005) Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentrationdependent manner. Can J Vet Res 69:151-154.
33. Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, Muzaffar S, and Kohen F (2003) Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114-122.
34. Notas G, Nifli AP, Kampa M, Vercauteren J, Kouroumalis E, and Castanas E (2006) Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta 1760:1657-1666.
35. Ovesn á Z, Kozics K, Bader Y, Saiko P, Handler N, Erker T, and Szekeres T (2006) Antioxidant activity of resveratrol, piceatannol and 3,3′,4,4′,5,5′-hexahydroxytrans-stilbene in three leukemia cell lines. Oncol Rep 16:617-624.
36. Rajan AJ, Asensio VC, Campbell IL, and Brosnan CF (2000) Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J Immunol 164:2120-2130.
37. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, and Luster AD (1996) Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 2:334-348.
38. Schroecksnadel K, Winkler C, Wirleitner B, Schennach H, Weiss G, and Fuchs D (2005) Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro. Clin Chem Lab Med 43:1084-1088.
39. Seo KS, Lee SU, Park YH, Davis WC, Fox LK, and Bohach GA (2007) Long-term staphylococcal enterotoxin C1 exposure induces soluble factor mediated immunosuppression by bovine CD4+ and CD8+ T cells. Infect Immun 75:260-269.
40. Singh NP, Nagarkatti M, and Nagarkatti PS (2007) Role of dioxin response element and nuclear factor-κB motifs in 2,3,7,8-tetrachlorodibenzo-p- dioxin-mediated regulation of Fas and Fas ligand expression. Mol Pharmacol 71:145-157.
41. Soleas GJ, Diamandis EP, and Goldberg DM (1997) Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11:287-313.
42. Sospedra M and Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747.
43. Su JL, Lin MT, Hong CC, Chang CC, Shiah SG, Wu CW, Chen ST, Chau YP, and Kuo ML (2005) Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 26:1-10.
44. Wirleitner B, Schroecksnadel K, Winkler C, Schennach H, and Fuchs D (2005) Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Immunol Lett 100:159-163.
45. Zhou HB, Chen JJ, Wang WX, Cai JT, and Du Q (2005) Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 11:280-284.